MarketInOut Stock Screener Log In | Sign Up

Apotex Health Corp

TSX • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 16:00
Apotex Health Corp stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTSX
Market Capitalization7,325.68 mln
Float94.29 mln
Earnings Date11/12/2026

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-3.02
Reliable

1-Year Forecast

41.37
Strong upside

Relative Strength

91 / 100
Top performer

Debt / Equity

8.63
Extremely leveraged

Pre-Tax Margin

15%
Healthy margin

Business Description

Apotex Health Corp. is a Canadian pharmaceutical company founded in 1974 and headquartered in Toronto, with operations across the United States, Mexico, and India. The company makes and sells a wide range of medicines, including generic drugs, cancer treatments, biosimilars, and consumer health products. It is a subsidiary of SK Artemis Holdings II LLC and was previously known as Artemis Parent Inc. before adopting its current name in May 2026.

Key Fundamentals

EPS-0.14
ROE-280
RPS16.39
ROIC20.31
ROA7.96
Interest Cover4.19
EBITDA, mln936
EV / EBITDA11.54
EV / EBIT13.73
Revenue, mln3,491
EV / Revenue3.09

Quote Details

Last 32.53
Change 0.2 (0.62%)
Open 32.33
Volume 168,886
Turnover 5,493,862
Average Volume 327,893

Financial Ratios

Pre-Tax Profit Margin15
Current Ratio1.50
Price / Book20.91
Price / Cash Flow11.59
Price / Free Cash Flow14.02
Debt / Equity8.63
Price / Sales2.09

Financial Strength

Altman Z-Score2.1
Piotroski F-Score 7 / 9
Beneish M-Score-3.02
1-Year Target Price41.37
Short Ratio2.33

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.09% 52 / 100   
1 Month -0.52% 48 / 100   
2 Months -13.19% 10 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog